dupilumab Flashcards
1
Q
main indication
A
add on in uncontrolled moderate/severe eosinophilic asthma
2
Q
mechanism of action
A
blocks the effects of the TH2 cytokines IL-4/13 which are responsible for eosinophilic inflammation, IgE, airway hyper reactivity and mucin production in asthma
3
Q
administration
A
injection every 2 weeks (expensive)
